Introduction of dominant inhibitory proteins directed against ROK and MRCK kinases.
Tan
Ivan
I
Glaxo-IMCB Laboratory, Institute of Molecular and Cell Biology, Singapore.
Lim
Louis
L
Leung
Thomas
T
D000818:Animals; D005455:Fluorescent Antibody Technique / Q000379:methods; D006367:HeLa Cells; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008081:Liposomes / Q000378:metabolism; D008845:Microinjections / Q000379:methods; D065636:Myotonin-Protein Kinase; D016716:PC12 Cells; D010957:Plasmids / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction; D014162:Transfection / Q000379:methods; D054460:rho-Associated Kinases
C585517:DMPK protein, human; D047908:Intracellular Signaling Peptides and Proteins; D008081:Liposomes; D065636:Myotonin-Protein Kinase; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases